Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
Noise & Health  
 Next article
 Previous article
Table of Contents

Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Citation Manager
Access Statistics
Reader Comments
Email Alert *
Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded115    
    Comments [Add]    

Recommend this journal


Year : 1999  |  Volume : 2  |  Issue : 5  |  Page : 53--69

Evidence of a common pathway in noise-induced hearing loss and carboplatin ototoxicity

1 Center for Hearing and Deafness, SUNY at Buffalo, 215 Parker Hall, Buffalo, New York 14214, USA
2 Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, P.R., China

Correspondence Address:
Donald Henderson
Center for Hearing and Deafness, 215 Parker Hall, State University of New York at Buffalo, Buffalo, NY 14214
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 12689485

Rights and PermissionsRights and Permissions

In spite of the differences in the nature of the insult, the hearing loss from ototoxic drugs and noise exposure share a number of similarities in cochlear pathology. This paper explores the common factors between noise-induced hearing loss and ototoxicity by experimentally manipulating cochlear glutathione (GSH). In the first experiment, chinchillas were treated with a drop of saline (50 l) on the round window of one ear and a drop of buthionine sulfoximine (BSO, 50 l of 200 mM) on the other ear. BSO is a drug that blocks GSH synthesis and it was hypothesized that GSH-depressed ears would be more vulnerable to noise. Six hours after treatment, the animals were exposed to a 105 dB 4 kHz octave band noise for 4 hours, then a second dose of BSO was applied 2 hours later. The BSO treated ears showed more temporary threshold shifts and reduced GSH staining at day 4 post exposure, but there was no BSO effect in terms of greater permanent threshold shift (PTS) or hair cell loss. In the second experiment, chinchillas were pretreated with BSO and 3 days later were given either a single dose of carboplatin (25 mg/kg i.p.), a double dose (day 3 and 7) or only BSO. Chinchillas that received BSO and the double dose of carboplatin had significantly greater loss of inner and outer hair cells than the carboplatin chinchillas. In addition, the BSO and carboplatin chinchillas also had larger decreases in evoked response amplitudes suggesting that GSH depletion potentiated the ototoxicity of carboplatin. These results are discussed in terms of the role of reactive oxygen species in creating hearing loss and the potential protective role of glutathione.


Print this article     Email this article